GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for probable dual-specificity RNA methyltransferase rlmn (A7GG92)

Analyse AlphaFold monomer V2.0 prediction for probable dual-specificity RNA… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A7GG92
Type
protein
Length
342 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x5e58272ea25a05e06901A2eAe9f63939b344e0c6
Molecule
Probable dual-specificity RNA methyltransferase rlmn
UniProt
A7GG92
Pockets
3 · best druggability 0.80

Structure

1 distinct chain · 39% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable dual-specificity RNA methyltransferase rlmnprotein34239% helix, 22% strandA7GG92

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11420.800.9729empty
2520.600.9218empty
32530.540.7724empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.